Back to User profile » Dr Shenglan Huang
Paper published by Dr Shenglan Huang:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
Liu K, Wu J, Xu Y, Li D, Huang S, Mao Y
OncoTargets and Therapy 2022, 15:1079-1094
Published Date: 1 October 2022